Clinigence Holdings Inc ( (NUTX) ) has released its Q4 earnings. Here is a breakdown of the information Clinigence Holdings Inc presented to its investors.
Nutex Health Inc., headquartered in Houston, Texas, operates as a healthcare management and operations company, specializing in micro-hospitals and hospital outpatient departments across 11 states, alongside managing provider networks through its Population Health Management division.
Nutex Health Inc. has reported a remarkable financial turnaround for the fiscal year 2024, showcasing a significant increase in total revenue to $479.9 million, a 93.8% rise from the previous year. The company also achieved a net income of $52.2 million, a stark contrast to the net loss of $45.8 million in 2023, with a diluted EPS of $9.71 per share.
Key financial metrics highlight the company’s robust performance, with EBITDA reaching $98.4 million and adjusted EBITDA soaring to $123.7 million, marking an impressive 1,045.4% increase. The arbitration process played a pivotal role, contributing approximately $169.7 million in additional revenue. The Hospital Division saw a 16.9% increase in total visits, reflecting operational improvements and a focus on higher ER acuity and enhanced service mix.
The fourth quarter of 2024 alone saw a revenue surge to $257.6 million, a 269.6% increase from the same period in 2023, driven largely by arbitration efforts. The company reported a net income of $61.7 million for the quarter, further solidifying its financial recovery and operational efficiency.
Looking ahead, Nutex Health’s management remains optimistic about maintaining its growth trajectory in 2025, focusing on operational optimization and cost management to support sustained expansion. The company enters the new year with strong momentum, aiming to continue its financial and operational success.